CSF3 and cervical carcinoma: Moreover, the G-CSF-positive cervical cancer patients exhibited marginally shorter progression-free survival (PFS) than the G-CSF-negative cervical cancer patients (median PFS: 8.5 months vs. 20 months, p = 0.0687), indicating that the responses of the G-CSF-positive cervical cancer patients did not last as long as those of G-CSF-negative cervical cancer patients (Supplementary Figure S1A).